MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets

Meningiomas, characterized primarily as benign intracranial or spinal tumors, present distinctive challenges due to their variable clinical behavior, with certain cases exhibiting aggressive features linked to elevated morbidity and mortality. Despite their prevalence, the underlying molecular mecha...

Full description

Bibliographic Details
Main Authors: Ozal Beylerli, Tatiana Ilyasova, Huaizhang Shi, Albert Sufianov
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2024-09-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054024000325
_version_ 1797234060053970944
author Ozal Beylerli
Tatiana Ilyasova
Huaizhang Shi
Albert Sufianov
author_facet Ozal Beylerli
Tatiana Ilyasova
Huaizhang Shi
Albert Sufianov
author_sort Ozal Beylerli
collection DOAJ
description Meningiomas, characterized primarily as benign intracranial or spinal tumors, present distinctive challenges due to their variable clinical behavior, with certain cases exhibiting aggressive features linked to elevated morbidity and mortality. Despite their prevalence, the underlying molecular mechanisms governing the initiation and progression of meningiomas remain insufficiently understood. MicroRNAs (miRNAs), small endogenous non-coding RNAs orchestrating post-transcriptional gene expression, have garnered substantial attention in this context. They emerge as pivotal biomarkers and potential therapeutic targets, offering innovative avenues for managing meningiomas. Recent research delves into the intricate mechanisms by which miRNAs contribute to meningioma pathogenesis, unraveling the molecular complexities of this enigmatic tumor. Meningiomas, originating from arachnoid meningothelial cells and known for their gradual growth, constitute a significant portion of intracranial tumors. The clinical challenge lies in comprehending their progression, particularly factors associated with brain invasion and heightened recurrence rates, which remain elusive. This comprehensive review underscores the pivotal role of miRNAs, accentuating their potential to advance our comprehension of meningioma biology. Furthermore, it suggests promising directions for developing diagnostic biomarkers and therapeutic interventions, holding the promise of markedly improved patient outcomes in the face of this intricate and variable disease.
first_indexed 2024-04-24T16:26:03Z
format Article
id doaj.art-abb1c3838f204baf89e795a21abea4e4
institution Directory Open Access Journal
issn 2468-0540
language English
last_indexed 2024-04-24T16:26:03Z
publishDate 2024-09-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj.art-abb1c3838f204baf89e795a21abea4e42024-03-31T04:37:50ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402024-09-0193641648MicroRNAs in meningiomas: Potential biomarkers and therapeutic targetsOzal Beylerli0Tatiana Ilyasova1Huaizhang Shi2Albert Sufianov3Central Research Laboratory, Bashkir State Medical University, Republic of Bashkortostan, 3 Lenin Street, Ufa, 450008, Russia; Corresponding author.Department of Internal Diseases, Bashkir State Medical University, Republic of Bashkortostan 450008, Ufa, RussiaDepartment of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaEducational and Scientific Institute of Neurosurgery, Рeoples’ Friendship University of Russia (RUDN University), Moscow, Russia; Department of Neurosurgery, Sechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaMeningiomas, characterized primarily as benign intracranial or spinal tumors, present distinctive challenges due to their variable clinical behavior, with certain cases exhibiting aggressive features linked to elevated morbidity and mortality. Despite their prevalence, the underlying molecular mechanisms governing the initiation and progression of meningiomas remain insufficiently understood. MicroRNAs (miRNAs), small endogenous non-coding RNAs orchestrating post-transcriptional gene expression, have garnered substantial attention in this context. They emerge as pivotal biomarkers and potential therapeutic targets, offering innovative avenues for managing meningiomas. Recent research delves into the intricate mechanisms by which miRNAs contribute to meningioma pathogenesis, unraveling the molecular complexities of this enigmatic tumor. Meningiomas, originating from arachnoid meningothelial cells and known for their gradual growth, constitute a significant portion of intracranial tumors. The clinical challenge lies in comprehending their progression, particularly factors associated with brain invasion and heightened recurrence rates, which remain elusive. This comprehensive review underscores the pivotal role of miRNAs, accentuating their potential to advance our comprehension of meningioma biology. Furthermore, it suggests promising directions for developing diagnostic biomarkers and therapeutic interventions, holding the promise of markedly improved patient outcomes in the face of this intricate and variable disease.http://www.sciencedirect.com/science/article/pii/S2468054024000325MeningiomasMicroRNAsBiomarkersTherapeutic targetsTumorigenesisIntracranial tumors
spellingShingle Ozal Beylerli
Tatiana Ilyasova
Huaizhang Shi
Albert Sufianov
MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets
Non-coding RNA Research
Meningiomas
MicroRNAs
Biomarkers
Therapeutic targets
Tumorigenesis
Intracranial tumors
title MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets
title_full MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets
title_fullStr MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets
title_full_unstemmed MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets
title_short MicroRNAs in meningiomas: Potential biomarkers and therapeutic targets
title_sort micrornas in meningiomas potential biomarkers and therapeutic targets
topic Meningiomas
MicroRNAs
Biomarkers
Therapeutic targets
Tumorigenesis
Intracranial tumors
url http://www.sciencedirect.com/science/article/pii/S2468054024000325
work_keys_str_mv AT ozalbeylerli micrornasinmeningiomaspotentialbiomarkersandtherapeutictargets
AT tatianailyasova micrornasinmeningiomaspotentialbiomarkersandtherapeutictargets
AT huaizhangshi micrornasinmeningiomaspotentialbiomarkersandtherapeutictargets
AT albertsufianov micrornasinmeningiomaspotentialbiomarkersandtherapeutictargets